LivaNova (LIVN) Share-based Compensation Growth (5y) (2021 - 2026)
LivaNova (LIVN) Share-based Compensation Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | LivaNova | 4.37 Bn | 3.83 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81% |
| Dec 31, 2025 | 15.30% |
| Sep 30, 2025 | -15.24% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | -2.96% |
| Dec 31, 2024 | 51.14% |
| Sep 30, 2024 | 78.75% |
| Jun 30, 2024 | 49.23% |
| Mar 31, 2024 | 17.29% |
| Dec 31, 2023 | 39.61% |
| Sep 30, 2023 | -30.60% |
| Jun 30, 2023 | -10.77% |
| Mar 31, 2023 | -25.08% |
| Dec 31, 2022 | 26.28% |
| Sep 30, 2022 | 13.53% |
| Jun 30, 2022 | 19.51% |
| Mar 31, 2022 | 21.69% |
| Dec 31, 2021 | 20.12% |
| Sep 30, 2021 | 18.46% |
| Mar 31, 2021 | 9.29% |